Timothy D. Aungst, PharmD

home / authors / timothy-d-aungst-pharmd

Articles

What is the Current Status of Bioingestible Sensors for Medication Adherence?

What is the Current Status of Bioingestible Sensors for Medication Adherence?

Timothy D. Aungst, PharmD
January 18th 2020

Sensors that can be attached to insulin pens, smart auto-injectors for patients with MS, sensors for inhalers, smart pill bottles, and bioingestible sensors are some of the evolving technologies.

Read More

Turning to Technology for Managing Drug Shortages

Turning to Technology for Managing Drug Shortages

Timothy D. Aungst, PharmD
July 3rd 2019

One company, LogicStream Health, creates software that integrates with a hospital EHR system for multiple platform services.

Read More

Site Logo

Pharmacists Reaching Out in Multiple Sclerosis: Integrating Digital Technology to Support Patient Care

Timothy D. Aungst, PharmD;Aimee M. Banks, PharmD, BCPS, MSCS;Brandon M. Markley, PharmD, BCPS
May 13th 2019

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD